Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

IMPRINT

ARENSIA Exploratory Medicine GmbH
Merowingerplatz 1
40225 Düsseldorf
Germany

Legal Representatives
Geschaeftsfuehrer / Managing Director: Dr. Claudia Hesselmann / Dr. Jochen Kraatz / Armin Hesselmann
Amtsgericht / Local Court: Düsseldorf, HRB 64937

Umsatzsteuer-Identifikationsnummer gemäß §27a Umsatzsteuergesetz: DE 27629 5755

ARENSIA Privacy & Data Protection Policy

VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse